Augmedix Inc represents values of innovation, efficiency, and patient-centricity. As a leading provider of remote medical documentation services, Augmedix is committed to revolutionizing healthcare through the use of advanced technology. The company's corporate philosophy revolves around enhancing the healthcare experience for both patients and providers. Augmedix leverages its proprietary platform to streamline clinical workflows, allowing healthcare professionals to focus on delivering high-quality care. By embracing a patient-centric approach, the company aims to improve access to healthcare services, reduce administrative burdens, and ultimately enhance patient outcomes. Augmedix Inc's dedication to innovation and efficiency sets it apart in the rapidly evolving digital healthcare industry.

Augmedix Inc is primarily present in the United States.

Augmedix Inc has achieved several significant milestones. Firstly, the company secured major funding rounds, raising a total of $90 million in investment. Secondly, Augmedix expanded its operations by partnering with leading healthcare providers and successfully implementing its virtual medical documentation platform. Thirdly, the company received recognition and awards, including being named one of the Most Innovative Companies in Healthcare by Fast Company. Additionally, Augmedix has witnessed substantial growth with its platform being used by healthcare professionals across numerous clinics and hospitals. These milestones highlight Augmedix Inc's success in revolutionizing the healthcare industry with its innovative technology and services.

Augmedix Inc is a leading healthcare technology company specialized in providing documentation solutions for doctors and physicians. Founded in 2012, Augmedix has revolutionized the healthcare industry by introducing a unique platform that enables healthcare professionals to focus more on patient care, rather than administrative tasks. Through their innovative technology, the company has successfully integrated artificial intelligence and virtual scribes to streamline the documentation process, improving efficiency and accuracy in medical records. Augmedix Inc has gained recognition for its transformative solutions, partnering with over 1,000 healthcare organizations worldwide. With its commitment to enhancing patient care, Augmedix continues to spearhead advancements in healthcare documentation services.

The main competitors of Augmedix Inc in the market are companies like Doximity, Notable, PrognoCIS, and Suki.

Augmedix Inc is primarily active in the healthcare industry.

The business model of Augmedix Inc revolves around providing remote medical scribe services to healthcare providers. Augmedix utilizes wearable technology, such as smart glasses, to capture and transmit real-time patient data to professional medical scribes. These scribes then document and transcribe the patient-physician interaction, allowing doctors to focus on patient care. Augmedix's innovative approach enhances physician productivity, reduces administrative burden, and improves healthcare services. By harnessing technology to optimize documentation, Augmedix enables more efficient and accurate patient record-keeping, ultimately leading to improved patient outcomes and streamlined workflows for healthcare providers.

De Augmedix K/W is -3,86.

De Augmedix KUV is 1,91.

De AlleAktien Kwaliteitsscore voor Augmedix is 4/10.

De verwachte Augmedix omzet is 54,16 mln. USD.

De verwachte Augmedix winst is -26,72 mln. USD.

Augmedix Inc is a leading company in the field of medical records and workflow improvement. The company's business model is based on the implementation of virtual reality (VR) and artificial intelligence (AI) for the automatic creation of medical documentation. Augmedix specializes in efficiently serving doctor's offices, hospitals, and insurance companies. Augmedix's main product is an intuitive application that allows doctors to treat their patients more efficiently and quickly by reviewing medical records and providing diagnoses and treatments. The use of VR technology allows medical professionals to access relevant information while interacting with patients. Augmedix's AI saves doctors time and increases efficiency by automatically performing necessary steps while doctors focus on treating patients. The company also offers additional services and support to facilitate the integration of their technology into existing practice and workflow. By improving the efficiency and accuracy of medical documentation, Augmedix helps doctors increase productivity and optimize patient care. Additionally, Augmedix's technology saves time and costs for practice management, improving the operation of doctor's offices and hospitals. Augmedix also provides specialized training to educate medical professionals in VR technology and AI. The company has partnerships with major healthcare organizations such as Sutter Health and Dignity Health to implement the technology and enhance patient care. Augmedix's business model is based on a subscription model, where customers pay for access to the technology and related services. The average price for a monthly subscription is around $2,500 per doctor. The company is able to achieve high margins due to the high value of its services, the high quality of its technology, and the high demand for automation of medical records. Augmedix Inc is also expanding internationally and has already offered services in Canada, the UK, and Australia. The company has a strategic partnership with Google to further improve and expand its technology. It has also become a central element in the telehealth market, which has gained importance during the COVID-19 pandemic. In summary, Augmedix Inc's business model specializes in improving workflows in healthcare and automating medical records. Augmedix's technology is based on VR and AI to help doctors and medical professionals perform their work more efficiently and accurately. The company offers a variety of services and training to integrate its technology into existing practice and workflow. Augmedix's subscription model allows the company to achieve high margins and competitive advantages in a rapidly growing market.

Augmedix keert een dividend van 0 USD uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Augmedix of het bedrijf keert geen dividend uit.

De ISIN van Augmedix is US05105P1075.

De ticker van Augmedix is AUGX.

Binnen de laatste 12 maanden betaalde Augmedix een dividend van . Dit komt overeen met een dividendrendement van ongeveer . Voor de komende 12 maanden zal Augmedix naar verwachting een dividend van 0 USD betalen.

De dividendrendement van Augmedix is momenteel .

Augmedix betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden .

Augmedix betaalde de afgelopen 0 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0 USD verwacht. Dit komt overeen met een dividendrendement van 0 %.

Augmedix wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Augmedix van 19-10-2024 ter hoogte van 0 USD te ontvangen, moest je het aandeel voor de ex-datum op 19-10-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 19-10-2024.

In het jaar 2023 heeft Augmedix 0 USD aan dividenden uitgekeerd.

De dividenden van Augmedix worden in USD uitgekeerd.